Everything you ever wanted to know about hair bonds and bond-building products, including how Olaplex, K18, and other ...

The first patient has been enrolled in the PROSTATE-IQ trial of ArteraAI, a multimodal artificial intelligence biomarker test ...

US FDA approves Novartis’ oral Fabhalta for treatment of adults with C3 glomerulopathy: Basel Saturday, March 22, 2025, 09:00 Hrs [IST] Novartis announced that oral Fabhalta (ip ...

After a very difficult childhood, professional life, and personal life, Preeti Vyas emerged with battle scars and honours, ...

Using an unbiased approach, this important study discovered a role of Ezh2 in the differentiation of granule neuron precursors, the cell of origin for Shh group of medulloblastoma. Furthermore, the ...

Waste Oils RecycLe and Development project, proposes an innovative, circular and sustainable process to turn used vegetable ...

The two men, who’d each been diagnosed with schizophrenia in their 20s and ended up in Alaska’s correctional system, should ...

Technosphere insulin, a rapid-acting human insulin administrated through an inhaler, was associated with reductions in HbA1c ...

Glance at our in-depth review of Bluehost. We bought and tested Bluehost, so read our full assessment and see what our ...

Under the BioVersys and GSK collaboration agreement, GSK is evaluating the early bactericidal activity (EBA) of alpibectir-ethionamide (AlpE) in a pulmonary tuberculosis (TB) trial, in combination ...

But in fact, tuberculosis is still the world’s deadliest infectious disease. It kills over 1.2 million people per year. That ...

Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), a self-sustainable, commercial-stage biotechnology company with clinical development programs focusing on organ fibrosis, today announced financial results ...